Abnormalities found in the laboratory blood results of our IBD patients (CRP, white blood cell count and platelet count, granulocyte count) are consistent with PORTO criteria, where evidence of decreased hemoglobin, elevated inflammatory markers, elevated platelet counts and low plasma albumin levels in patients presenting symptoms of IBD strongly predicts the diagnosis of IBD [17]. This evidence concerns the gene CRP and inflammatory bowel disease.